NIPA1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.336200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.492600E-01
Normal-vs-Stage2
4.370800E-01
Normal-vs-Stage3
9.798800E-01
Normal-vs-Stage4
5.940200E-01
Stage1-vs-Stage2
6.536000E-01
Stage1-vs-Stage3
2.657600E-01
Stage1-vs-Stage4
3.201000E-01
Stage2-vs-Stage3
3.544000E-01
Stage2-vs-Stage4
6.407600E-01
Stage3-vs-Stage4
6.740800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.352400E-01
Normal-vs-AfricanAmerican
3.994200E-01
Normal-vs-Asian
5.666200E-01
Caucasian-vs-AfricanAmerican
7.962000E-01
Caucasian-vs-Asian
8.161800E-01
AfricanAmerican-vs-Asian
9.900600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.396400E-01
Normal-vs-Female
4.486600E-01
Male-vs-Female
7.983400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.239600E-01
Normal-vs-Age(41-60Yrs)
2.348200E-01
Normal-vs-Age(61-80Yrs)
5.517000E-01
Normal-vs-Age(81-100Yrs)
8.477200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.458400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.814600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.902380E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.491500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.602200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.072800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.376600E-01
Normal-vs-Daily Drinker
6.212200E-01
Normal-vs-Weekly Drinker
6.985000E-01
Normal-vs-Occasional Drinker
1.997220E-01
Normal-vs-Social Drinker
6.997400E-01
Non Drinker-vs-Daily Drinker
5.377000E-01
Non Drinker-vs-Weekly Drinker
6.616000E-01
Non Drinker-vs-Occasional Drinker
5.814800E-01
Non Drinker-vs-Social Drinker
2.818200E-01
Daily Drinker-vs-Weekly Drinker
9.593600E-01
Daily Drinker-vs-Occasional Drinker
1.832240E-01
Daily Drinker-vs-Social Drinker
6.725400E-01
Weekly Drinker-vs-Occasional Drinker
3.331800E-01
Weekly Drinker-vs-Social Drinker
7.184600E-01
Occasional Drinker-vs-Social Drinker
6.316200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.018200E-02
Normal-vs-Grade 2
2.022100E-02
Normal-vs-Grade 3
6.116600E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.481200E-01
Grade 1-vs-Grade 3
1.266610E-01
Grade 1-vs-Grade 4
2.018200E-02
Grade 2-vs-Grade 3
6.843200E-01
Grade 2-vs-Grade 4
2.022100E-02
Grade 3-vs-Grade 4
6.116600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.036600E-01
Normal-vs-NonDiabetic
3.839200E-01
Diabetic-vs-NonDiabetic
1.652950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.611800E-01
Normal-vs-NoPancreatitis
4.778000E-01
Pancreatitis-vs-NoPancreatitis
2.282800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.466200E-01
Normal-vs-N1
4.251600E-01
N0-vs-N1
5.110600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.797840E-01
Normal-vs-TP53-NonMutant
4.353800E-01
TP53-Mutant-vs-TP53-NonMutant
1.228240E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
